Cited by

• Role of Teriparatide in Medication-Related Osteonecrosis of the Jaws (MRONJ).

  Kwon YD, Kim DY. Kwon YD, et al. Dent J (Basel). 2016 Nov 9;4(4):41. doi: 10.3390/dj4040041. Dent J (Basel). 2016. PMID: 29563483 Free PMC article. Review.
• Combined Effect of a Locking Plate and Teriparatide for Incomplete Atypical Femoral Fracture: Two Case Reports of Curved Femurs.

  Tsuchie H, Miyakoshi N, Nishi T, Abe H, Segawa T, Shimada Y. Tsuchie H, et al. Case Rep Orthop. 2015;2015:213614. doi: 10.1155/2015/213614. Epub 2015 May 26. Case Rep Orthop. 2015. PMID: 26101679 Free PMC article.
• The effects of teriparatide on acceleration of bone healing following atypical femoral fracture: comparison between daily and weekly administration.

  Tsuchie H, Miyakoshi N, Iba K, Kasukawa Y, Nozaka K, Dohke T, Kosukegawa I, Aizawa T, Maekawa S, Abe H, Takeshima M, Tomite T, Segawa T, Ouchi K, Kinoshita H, Suzuki M, Yamashita T, Shimada Y. Tsuchie H, et al. Osteoporos Int. 2018 Dec;29(12):2659-2665. doi: 10.1007/s00198-018-4658-7. Epub 2018 Aug 13. Osteoporos Int. 2018. PMID: 30105400
• Low-energy diaphyseal femoral fractures associated with bisphosphonate use and severe curved femur: a case series.

  Sasaki S, Miyakoshi N, Hongo M, Kasukawa Y, Shimada Y. Sasaki S, et al. J Bone Miner Metab. 2012 Sep;30(5):561-7. doi: 10.1007/s00774-012-0358-0. Epub 2012 May 19. J Bone Miner Metab. 2012. PMID: 22610061
• Evaluation of the Nature and Etiologies of Risk Factors for Diaphyseal Atypical Femoral Fractures.

  Tsuchie H, Miyakoshi N, Kasukawa Y, Nozaka K, Saito K, Kinoshita H, Kobayashi M, Suzuki N, Aizawa T, Abe H, Maekawa S, Tomite T, Ono Y, Ouchi K, Shibata N, Nagahata I, Takeshima M, Akagawa M, Yuasa Y, Sato C, Shimada Y. Tsuchie H, et al. Med Princ Pract. 2021;30(5):430-436. doi: 10.1159/000517484. Epub 2021 May 31. Med Princ Pract. 2021. PMID: 34058735 Free PMC article.